Evaluation of Macronutrient Intake of a Group of Multiple Sclerosis Patients in Jordan

Authors

  • Jamila H. Mraish Department of Nutrition and Food Technology, Faculty of Agriculture, The University of Jordan, Amman 11942, Jordan
  • Hamed R. Takruri Department of Nutrition and Food Technology, Faculty of Agriculture, The University of Jordan, Amman 11942, Jordan

DOI:

https://doi.org/10.3923/pjn.2016.763.770

Keywords:

Body mass index, Jordan, macronutrient intake, multiple sclerosis

Abstract

This study aimed at: evaluation of macronutrient intake and some of the anthropometric measurements (weight, height) and BMI (Body mass index) in a group of multiple sclerosis (MS) patients in Jordan. The study sample consisted of 60 subjects (47 females, 13 males), aged between 20-50 years, who attend the National Multiple Sclerosis Beta-Interferon Committee. A three-day food record was also used to collect dietary intake data. The studied sample was divided into three age groups: group 1: 20-29 years (n = 29), group 2: 30-39 years (n = 18) and group 3: 40-50 years (n = 13). The mean weight of the patients was 66.63 kg, mean height was 164.04 cm and mean BMI was 24.71. Sixty percent of the subjects had normal weight, whereas 5% had underweight status. Energy and carbohydrate intake of the whole sample was <90% of DRI (Dietary reference intake), whereas protein and fat intakes were >90% of recommended values. The intake of total polyunsaturated fatty acids, omega-3 and omega-6 were inadequate (42.2, 44.7 and 45.9% of DRI, respectively). It could be concluded that multiple sclerosis patients in Jordan generally have adequate macronutrient intakes, but inadequate intake of essential fatty acids. No significant differences could be found between sample age groups. However, both anthropometric and nutritional variables of the patients were affected by gender.

References

Alschuler, K.N., L.E. Gibbons, D.E. Rosenberg, D.M. Ehde, A.M. Verrall, A.M. Bamer and M.P. Jensen, 2012. Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome and spinal cord injury. Disability Health J., 5: 177-184.

Bahou, Y.G., M. Jaber, T. Al-Nimri and A. Ababneh, 2013. Characteristics of a series of Multiple Sclerosis (MS) patients observed at the national ms beta-interferon committee in Jordan over a one-yearperiod (August 2009-August 2010). Jordan Med. J., 47: 120-130.

Bates, D., N.E. Cartlidge, J.M. French, M.J. Jackson and S. Nightingale et al., 1989. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 52: 18-22.

Lassmann, H., W. Bruck and C.F. Lucchinetti, 2007. The immunopathology of multiple sclerosis: An overview. Brain Pathol., 17: 210-218.

Dworkin, R.H., D. Bates, J.H.D. Millar and D.W. Paty, 1984. Linoleic acid and multiple sclerosis: A reanalysis of three double-blind trials. Neurology, 34: 1441-1445.

Fantelli, F.J., H. Mitsumoto and B.A. Sebek, 1978. Multiple sclerosis and malabsorption. Lancet, 311: 1039-1040.

Formica, C.A., F. Cosman, J. Nieves, J. Herbert and R. Lindsay, 1997. Reduced bone mass and fat-free mass in women with multiple sclerosis: Effects of ambulatory status and glucocorticoid use. Calcified Tissue Int., 61: 129-133.

Gallai, V., P. Sarchielli, A. Trequattrini, M. Franceschini and A. Floridi et al., 1995. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J. Neuroimmunol., 56: 143-153.

Gibson, R.S., 2005. Principles of Nutritional Assessment. 2nd Edn., Oxford University Press, New York, USA., ISBN-13: 978-0195171693, Pages: 928.

Hewson, D.C., M.A. Phillips, K.E. Simpson, P. Drury and M.A. Crawford, 1984. Food intake in multiple sclerosis. Human Nutr. Applied Nutr., 38: 355-367.

Kamalian, N., R.E. Keesey and G.M. ZuRhein, 1975. Lateral hypothalamic demyelination and cachexia in a case of malignant multiple sclerosis. Neurology, 25: 25-30.

Kantarci, O. and D. Wingerchuk, 2006. Epidemiology and natural history of multiple sclerosis: New insights. Curr. Opin. Neurol., 19: 248-254.

Khurana, S.R., A.M. Bamer, A.P. Turner, R.V. Wadhwani, J.D. Bowen, S.L. Leipertz and J.K. Haselkorn, 2009. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am. J. Phys. Med. Rehab., 88: 83-91.

Lauer, K., 1997. Diet and multiple sclerosis. Neurology, 49: S55-S61.

Lee, R.D. and D.C. Neiman, 2009. Nutritional Assessment. 5th Edn., McGraw-Hill Education, New York, USA., ISBN-13: 9780073375564, 608.

MSIF., 2013. Atlas of MS 2013: Mapping multiple sclerosis around the world. Multiple Sclerosis International Federation (MSIF), London, UK. https://www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf.

Nortvedt, M.W., T. Riise and J.G. Mæland, 2005. Multiple sclerosis and lifestyle factors: The Hordaland health study. Neurol. Sci., 26: 334-339.

Orton, S.M., B.M. Herrera, I.M. Yee, W. Valdar, S.V. Ramagopalan, A.D. Sadovnick and G.C. Ebers, 2006. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol., 5: 932-936.

Payne, A., 2001. Nutrition and diet in the clinical management of multiple sclerosis. J. Hum. Nutr. Dietet., 14: 349-357.

Pellet, P.L. and S. Shadarevian, 1970. Food Composition Tables for use in the Middle East. 2nd Edn., American University of Beirut, Lebanon, Pages: 116.

Pilutti, L.A., D. Dlugonski, J.H. Pula and R.W. Motl, 2012. Weight status in persons with multiple sclerosis: Implications for mobility outcomes. J. Obes.

Saka, M., M. Saka, E. Koseler, S. Metin and S. Bilen et al., 2012. Nutritional status and anthropometric measurements of patients with multiple sclerosis. Saudi Med. J., 33: 160-166.

Schwarz, S. and H. Leweling, 2005. Multiple sclerosis and nutrition. Multiple Sclerosis, 11: 24-32.

Shirazi, M.M., F.A. Taleban and M. Ghafarpoor, 2007. Macronutrients intake in Iranian multiple sclerosis patients. J. Med. Sci., 7: 422-426.

Swank, R.L. and B.B. Dugan, 1990. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet, 336: 37-39.

Swank, R.L. and J. Goodwin, 2003. Review of MS patient survival on a Swank low saturated fat diet. Nutrition, 19: 161-162.

Swank, R.L., 1953. Treatment of multiple sclerosis with low-fat diet. Arch. Neurol. Psychiatry, 69: 91-103.

Timmerman, G.M. and A.K. Stuifbergin, 1999. Eating patterns in women with multiple sclerosis. J. Neur. Nurs., 31: 152-158.

WHO., 1990. Diet, nutrition and the prevention of chronic diseases. Technical Report Series No. 797, World Health Organization, Geneva.

Zhang, S.M., W.C. Willett, M.A. Hernan, M.J. Olek and A. Ascherio, 2000. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am. J. Epidemiol., 152: 1056-1064.

Downloads

Published

15.07.2016

Issue

Section

Research Article

How to Cite

Mraish, J. H., & Takruri, H. R. (2016). Evaluation of Macronutrient Intake of a Group of Multiple Sclerosis Patients in Jordan. Pakistan Journal of Nutrition, 15(8), 763–770. https://doi.org/10.3923/pjn.2016.763.770